成人先天性心脏病癌症筛查覆盖率评价

IF 18 Q4 Medicine
M. Albertini , P. David , S. Hascoet , M. Ladouceur , L. Guirgis , E. Fournier , I. Van Aerschot , J. Radojevic , V. Waldmann , L. Iserin , S. Cohen
{"title":"成人先天性心脏病癌症筛查覆盖率评价","authors":"M. Albertini ,&nbsp;P. David ,&nbsp;S. Hascoet ,&nbsp;M. Ladouceur ,&nbsp;L. Guirgis ,&nbsp;E. Fournier ,&nbsp;I. Van Aerschot ,&nbsp;J. Radojevic ,&nbsp;V. Waldmann ,&nbsp;L. Iserin ,&nbsp;S. Cohen","doi":"10.1016/j.acvdsp.2023.07.030","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><p>The risk of cancer in adults with congenital heart disease (ACHD) is 23% higher than in the general population.</p></div><div><h3>Objective</h3><p>The objective of our study was to assess cancer screening coverage in ACHD.</p></div><div><h3>Methods</h3><p>This was a prospective, observational, bicentric study of ACHD patients. Data were collected through a self-questionnaire proposed to all consecutive patients over 25 years from September 2022 to March 2023. Information on cervical, breast and colorectal cancer screening was collected and compared with screening data provided by Santé Publique France.</p></div><div><h3>Results/Expected results</h3><p>A total of 263 patients were included. The mean age was 44 years (range, 25–78), 122 (46%) patients were male, and 99 (38%) patients had a complex CHD. Eleven (4%) patients had a history of cancer. The screening participation rate for breast cancer was higher in ACHD patients (72%) compared to the general population from Ile de France region (39%, <em>P</em> <!-->&lt;<!--> <!-->0.001) and from the whole French population (51%, <em>P</em> <!-->=<!--> <!-->0.002). For colorectal and cervical cancers, the screening participation rate were 36% and 65%, compared to 31% and 51% in Île de France region and 34% and 59% in the whole French population, respectively with no statistically significant difference (<span>Figure 1</span>).</p></div><div><h3>Conclusion/Perspectives</h3><p>Cancer screening coverage in ACHD patients was greater than non-congenital patients for breast cancer, but comparable for colorectal and cervical cancers. The screening participation rate remained however lower than European objectives for all cancers. Our data call for specific actions to better screen this aging population at high risk for cancer.</p></div>","PeriodicalId":8140,"journal":{"name":"Archives of Cardiovascular Diseases Supplements","volume":"15 4","pages":"Page 287"},"PeriodicalIF":18.0000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Evaluation of cancer screening coverage in adults with congenital heart disease\",\"authors\":\"M. Albertini ,&nbsp;P. David ,&nbsp;S. Hascoet ,&nbsp;M. Ladouceur ,&nbsp;L. Guirgis ,&nbsp;E. Fournier ,&nbsp;I. Van Aerschot ,&nbsp;J. Radojevic ,&nbsp;V. Waldmann ,&nbsp;L. Iserin ,&nbsp;S. Cohen\",\"doi\":\"10.1016/j.acvdsp.2023.07.030\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Introduction</h3><p>The risk of cancer in adults with congenital heart disease (ACHD) is 23% higher than in the general population.</p></div><div><h3>Objective</h3><p>The objective of our study was to assess cancer screening coverage in ACHD.</p></div><div><h3>Methods</h3><p>This was a prospective, observational, bicentric study of ACHD patients. Data were collected through a self-questionnaire proposed to all consecutive patients over 25 years from September 2022 to March 2023. Information on cervical, breast and colorectal cancer screening was collected and compared with screening data provided by Santé Publique France.</p></div><div><h3>Results/Expected results</h3><p>A total of 263 patients were included. The mean age was 44 years (range, 25–78), 122 (46%) patients were male, and 99 (38%) patients had a complex CHD. Eleven (4%) patients had a history of cancer. The screening participation rate for breast cancer was higher in ACHD patients (72%) compared to the general population from Ile de France region (39%, <em>P</em> <!-->&lt;<!--> <!-->0.001) and from the whole French population (51%, <em>P</em> <!-->=<!--> <!-->0.002). For colorectal and cervical cancers, the screening participation rate were 36% and 65%, compared to 31% and 51% in Île de France region and 34% and 59% in the whole French population, respectively with no statistically significant difference (<span>Figure 1</span>).</p></div><div><h3>Conclusion/Perspectives</h3><p>Cancer screening coverage in ACHD patients was greater than non-congenital patients for breast cancer, but comparable for colorectal and cervical cancers. The screening participation rate remained however lower than European objectives for all cancers. Our data call for specific actions to better screen this aging population at high risk for cancer.</p></div>\",\"PeriodicalId\":8140,\"journal\":{\"name\":\"Archives of Cardiovascular Diseases Supplements\",\"volume\":\"15 4\",\"pages\":\"Page 287\"},\"PeriodicalIF\":18.0000,\"publicationDate\":\"2023-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Archives of Cardiovascular Diseases Supplements\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1878648023002513\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of Cardiovascular Diseases Supplements","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1878648023002513","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

成人先天性心脏病(ACHD)患者患癌症的风险比一般人群高23%。本研究的目的是评估ACHD的癌症筛查覆盖率。方法:这是一项前瞻性、观察性、双中心的ACHD患者研究。从2022年9月至2023年3月,通过对所有连续25年的患者进行自我问卷调查收集数据。收集了有关宫颈癌、乳腺癌和结直肠癌筛查的信息,并对法国圣公共机构提供的筛查数据进行了比较。结果/预期结果共纳入263例患者。平均年龄44岁(25-78岁),男性122例(46%),合并冠心病99例(38%)。11例(4%)患者有癌症病史。ACHD患者的乳腺癌筛查参与率(72%)高于法兰西岛地区的一般人群(39%,P <0.001)和整个法国人口(51%,P = 0.002)。结直肠癌和宫颈癌的筛查参与率分别为36%和65%,而Île de France地区的筛查参与率分别为31%和51%,整个法国人口的筛查参与率分别为34%和59%,差异无统计学意义(图1)。结论/观点ACHD患者的乳腺癌筛查覆盖率高于非先天性患者,但结直肠癌和宫颈癌的筛查覆盖率相当。然而,所有癌症的筛查参与率仍然低于欧洲的目标。我们的数据要求采取具体行动,更好地筛查癌症高风险的老年人群。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Evaluation of cancer screening coverage in adults with congenital heart disease

Introduction

The risk of cancer in adults with congenital heart disease (ACHD) is 23% higher than in the general population.

Objective

The objective of our study was to assess cancer screening coverage in ACHD.

Methods

This was a prospective, observational, bicentric study of ACHD patients. Data were collected through a self-questionnaire proposed to all consecutive patients over 25 years from September 2022 to March 2023. Information on cervical, breast and colorectal cancer screening was collected and compared with screening data provided by Santé Publique France.

Results/Expected results

A total of 263 patients were included. The mean age was 44 years (range, 25–78), 122 (46%) patients were male, and 99 (38%) patients had a complex CHD. Eleven (4%) patients had a history of cancer. The screening participation rate for breast cancer was higher in ACHD patients (72%) compared to the general population from Ile de France region (39%, P < 0.001) and from the whole French population (51%, P = 0.002). For colorectal and cervical cancers, the screening participation rate were 36% and 65%, compared to 31% and 51% in Île de France region and 34% and 59% in the whole French population, respectively with no statistically significant difference (Figure 1).

Conclusion/Perspectives

Cancer screening coverage in ACHD patients was greater than non-congenital patients for breast cancer, but comparable for colorectal and cervical cancers. The screening participation rate remained however lower than European objectives for all cancers. Our data call for specific actions to better screen this aging population at high risk for cancer.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Archives of Cardiovascular Diseases Supplements
Archives of Cardiovascular Diseases Supplements CARDIAC & CARDIOVASCULAR SYSTEMS-
自引率
0.00%
发文量
508
期刊介绍: Archives of Cardiovascular Diseases Supplements is the official journal of the French Society of Cardiology. The journal publishes original peer-reviewed clinical and research articles, epidemiological studies, new methodological clinical approaches, review articles, editorials, and Images in cardiovascular medicine. The topics covered include coronary artery and valve diseases, interventional and pediatric cardiology, cardiovascular surgery, cardiomyopathy and heart failure, arrhythmias and stimulation, cardiovascular imaging, vascular medicine and hypertension, epidemiology and risk factors, and large multicenter studies. Additionally, Archives of Cardiovascular Diseases also publishes abstracts of papers presented at the annual sessions of the Journées Européennes de la Société Française de Cardiologie and the guidelines edited by the French Society of Cardiology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信